Gestational diabetes mellitus (GDM) is a prevalent condition affecting approximately 7% of all pregnancies. As healthcare professionals, optimizing patient outcomes through comprehensive management is paramount. This article provides an overview of the best practices for managing this condition.
Early detection is crucial in managing GDM. The American Diabetes Association recommends universal screening for all pregnant women between 24 and 28 weeks of gestation using the glucose challenge test. A diagnosis is confirmed if the plasma glucose level one hour after a 50-gram glucose load is ≥140 mg/dL.
Dietary intervention is the cornerstone of GDM management. It involves meal planning to ensure appropriate weight gain, adequate nutrition, and euglycemia. A registered dietitian should provide individualized Medical Nutrition Therapy (MNT) to all GDM patients.
Regular physical activity complements MNT in managing GDM. It improves insulin sensitivity and aids in achieving euglycemia. Moderate-intensity exercise, such as brisk walking for at least 30 minutes daily, is recommended unless contraindicated.
If diet and exercise fail to achieve euglycemia, pharmacologic therapy is initiated. Insulin is the first-line treatment. However, oral hypoglycemic agents like metformin and glyburide are also considered safe and effective.
Postpartum care includes glucose testing 6-12 weeks after delivery to exclude type 2 diabetes, with lifelong screening for the development of diabetes or prediabetes. Lifestyle modifications should continue to prevent diabetes.
Optimizing outcomes in GDM involves a multidisciplinary approach encompassing screening, dietary intervention, physical activity, pharmacologic therapy, and vigilant postpartum care. As healthcare professionals, we play a pivotal role in managing this condition, thereby improving maternal and neonatal outcomes.
1.
Can Children With Low-Risk Hodgkin Lymphoma Skip Radiation?
2.
The need for more Latinx participants in Alzheimer's trials is urgent.
3.
Admissions, medical colleges, fees, and eligibility requirements information for the DNB Post Diploma in Radiation Oncology.
4.
Study identifies new approach to protect the brain during radiation therapy
5.
Study Supports Lactated Ringer Solution for Fluid Resuscitation in SCD
1.
CAR-T Cell Therapy for B-Cell Acute Lymphoblastic Leukemia: A Comprehensive Review
2.
Treating Oral Fibromas: Options and Guidelines for a Healthier Mouth
3.
The Genetics of Bernard Soulier Syndrome: What We Know so Far
4.
Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology
5.
Unlocking The Power Of Cangrelor To Treat Heart Disease
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.
2.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
3.
Navigating the Complexities of Ph Negative ALL - Part XV
4.
Lung Cancer: Risk Factors and Prevention
5.
Thromboprophylaxis In Medical Settings
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation